Skip to main content

Posts Tagged ‘pharma’

10 Tips On How To Discuss Genome Sequencing With Family Members

  In 2009, the cost for a consumer to sequence his or her genome was $49,000. It’s all the way down to $1,000 today. As the price continues to become more affordable, the frequency of the average Joe sequencing his genome will likely increase. However, many individuals are wary of the idea of knowing more […]

Top 5 Life Sciences Blog Posts From September 2015

  Now that October is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in September – they’re ranked in order of popularity, with number one being the most viewed piece. 

How Roche’s App Will Shape The Future Of Parkinson’s Disease

  Check this out. Roche just developed a mobile app, which is currently being evaluated in a Phase I trial, that can help assess the severity of one’s Parkinson’s disease (PD). Here’s how it works: Patients are provided with pre-configured smartphones and, over time, are guided through a series of tests to collect data points. […]

Were Kim Kardashian’s Instagram Posts Worth It?

Since the infamous Kim Kardashian Instagram post went up and the FDA issued a Warning Letter to Duchesnay, the company she was representing, a couple of things have happened. For one, Kim has issued a corrective post (i.e., ad), which outlined the safety information for Diclegis, the medication for morning sickness she is promoting. And, […]

A Facebook Post Gets Pfizer To Discuss Prescription Drug Abuse

  If you visit the Gloucester Police Department’s Facebook page, you’ll notice their posts from September 16th and 18th received thousands of likes, shares, and comments. That’s for good reason. On September 16th, the department called out five pharma CEOs with the highest salaries and urged readers to contact them and ask what they’re doing […]

One Of The Most Wild And Fascinating Stories Of The Year

  Turing Pharmaceuticals, the maker of Daraprim, a drug that treats toxoplasmosis (a parasitic disease), increased the cost of each tablet from $13.50 to $750. That’s right – more than a 5,000% increase. 

UCB’s EVP And CMO Opens Up About Digital Transformation

  Digital transformation (DT), the concept of leveraging digital technologies to engage with constituents (e.g., customers, patients, employees, or partners) is vital in today’s world. The audience you’re targeting expects communication to be easy and information to be readily available at any time. If they can’t get what they want from you, they’ll go somewhere […]

First Quintiles, Now PPD. Oracle Siebel CTMS Is Rockin’ It

  These days, it appears as if most of the big contract research organizations (CROs) are using Siebel CTMS, Oracle’s clinical trial management system. In June of this year, I wrote about Quintiles’ use of Oracle Health Sciences applications, including Siebel CTMS. Now we’re talking about PPD, another top-5 CRO. 

Some Rare Disease Stats That Make Them Seem Rather Common

  We often hear the term “rare disease,” yet many of us still wonder exactly how “rare” is defined. In a recent blog post, Dr. Jonathan Goldsmith, the FDA’s Associate Director for Rare Diseases, shared some staggering statistics, as well as insights into how the FDA is making it easier to develop drugs for unusual […]

Precision Medicine: A Highlight At Dreamforce 2015

  As many of you know, Perficient has a practice devoted to Salesforce.com solutions. So, it shouldn’t be a surprise that a bunch of my colleagues are at this year’s Dreamforce event and furiously blogging about what they’re hearing. One of the posts that caught my attention was from Mike Porter, who sat in Dr. […]

Don’t Be Left In The Dust By Digital Transformation

  It seems like every other day we’re reading about pharmaceutical companies developing mobile apps, or at the very least, investing in companies that develop them. And that’s for good reason: They work. They help researchers learn about disorders. They help educate patients on their conditions and provide treatment recommendations. They help with patient adherence. […]

Can Shazam’s Ex-CFO Help TrialReach Tune In To Patients?

  Keith Lovell just left Shazam, the company behind the popular app that magically tells you the artist performing the song playing in the background at Cheesecake Factory. With almost a decade as the company’s CFO, he chose to join TrialReach, a technology company focused on helping patients find the clinical trials they’re eligible for, based on […]

Load More